- 期刊
Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
延伸閱讀
- Martinez, A., Gil, C., & Perez, D. I. (2011). Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment. International Journal of Alzheimer＇s Disease, 2011(), 257-263. https://doi.org/10.4061/2011/280502
- Koistinaho, J., Malm, T., & Goldsteins, G. (2011). Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?. International Journal of Alzheimer＇s Disease, 2011(), 40-48. https://doi.org/10.4061/2011/129753
- Mehta, M., Adem, A., & Sabbagh, M. (2012). New Acetylcholinesterase Inhibitors for Alzheimer's Disease. International Journal of Alzheimer＇s Disease, 2012(), 765-772. https://doi.org/10.1155/2012/728983
- Crouch, P., Cole, A., Cousin, M., Martinez, A., & Kanninen, K. (2011). Glycogen Synthase Kinase-3. International Journal of Alzheimer＇s Disease, 2011(), 244-244. https://doi.org/10.4061/2011/279234
- Hanger, D. P., & Noble, W. (2011). Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation. International Journal of Alzheimer＇s Disease, 2011(), 375-385. https://doi.org/10.4061/2011/352805